R Welte - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R Welte

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Nature|March 24, 1994

EpidemiologyI R Dohoo, R S Morris, S W Martin, et al.

Vaccine|November 9, 2004

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-makingR Welte, G van den Dobbelsteen, J M Bos, et al.

European Journal of Medical Research|June 18, 2010

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in GermanyEva Wolf, M Blankenburg, J R Bogner, et al.

Nederlands Tijdschrift Voor Geneeskunde|December 29, 2000

[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]M J Postma, A Bakker, R Welte, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Nature|March 24, 1994

EpidemiologyI R Dohoo, R S Morris, S W Martin, et al.

Vaccine|November 9, 2004

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-makingR Welte, G van den Dobbelsteen, J M Bos, et al.

European Journal of Medical Research|June 18, 2010

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in GermanyEva Wolf, M Blankenburg, J R Bogner, et al.

Nederlands Tijdschrift Voor Geneeskunde|December 29, 2000

[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]M J Postma, A Bakker, R Welte, et al.

Pageof 3